FiNC Technologies Co., Ltd. announced that it has received round of funding on March 28, 2024. The transaction included the participation from returning investor Rohto Pharmaceutical Co.,Ltd. The company has raised the funding through third-party allotment method.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,083 JPY | +1.55% | +3.63% | +8.44% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.44% | 4.42B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- FiNC Technologies Co., Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.